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History of (animal) influenza virus surveillance 
WHO influenza programme established in 1952 
Formal surveillance programme since 1995 
(Interest in) surveillance spurred  
since 2000 
Several surveillance plans 
The complicated epidemiology of SIVs 
 
CAN 
USA 
1918: classical H1N1 (α clade) 
1998: 3 reassortant (3R) H3N2 
2001: reassortant H1N1&H1N2 
               (β,γ,δ clade) 
2009: pandemic H1N1 
 
1970: human-like H3N2 
1979: avian-like H1N1 
1994: reassortant H1N2 
2009: pandemic H1N1 
 
 
North America Europe 
• Co-circulation of multiple subtypes / lineages 
• Prevailing lineages differ in different regions 
The density of the swine population and pig 
farming practices differ in different regions 
    cf. Lina Awada 
The  basics about SI 
• enzootic,  non-notifiable 
• self-limiting disease, rarely fatal, 
    most infections subclinical 
• vaccine update/demand low in  
    some regions, most SIV vaccine 
used in sows 
• adjuvanted vaccines, no 
standardization 
Surveillance 
• Collect and analyze 
SIVs  (or serological 
data) 
• Interpretation of data 
• Timely dissemination 
of results to users of 
information 
NO CRYSTAL BALL!! 
   Example: Surveillance alone cannot tell us which 
SIV strains must be included in vaccines 
• No criteria to justify replacement or 
addition of vaccine strains: cross-HI 
with post-infection ferret sera, genetic 
homology are poor indicators of 
vaccine strain performance 
• Oil adjuvants broaden serological 
cross-reaction and cross-protection 
 Surveillance can assist with vaccine strain 
selection 
Example: surveillance cannot control future  
(swine -origin) influenza pandemics 
Push button risk assessment??? 
We don’t know what determines 
transmission of SIVs from pigs to 
humans or spread between 
humans!!! 
Surveillance can detect changes in SIVs or 
novel viruses in pigs and provide material for 
research on host adaptation 
Benefits for swine health 
1. Global picture of dominant SIV subtypes and 
lineages in different geographic regions 
 Apply information to update diagnostic 
technologies 
 Assistance with vaccine strain selection 
2. Better understanding of the antigenic and 
genetic evolution of SIVs 
Benefits for swine health 
Why slower antigenic drift with swine than with 
human viruses? Genetic changes outside 
antigenic domains? Which amino acids in the 
HA are most important? Differences in extent 
of drift between various subtypes/lineages? 
Extent of drift in NA as compared to HA?  
3. Indications as to determinants of virus 
adaptation to pigs and/or mechanisms of 
virulence 
e.g. dominant SIVs in North America and Europe have 
single type of internal gene cassette (triple-reassortant, 
avian-like) 
 
Benefits for swine health 
Pitfalls and limitations of surveillance 
• Genetic analysis: how reliable? 
overinterpretation? 
• Antigenic analysis: results highly variable, 
depending on reagents used 
• Serology has become of limited use in regions 
where several SIV lineages are co-circulating, 
may be useful to answer specific questions 
Benefits for swine health 
4. Better understanding of the epidemiology of SIV in 
swine farms or separate facts from speculation 
“Mathematical models …… workers can serve as a bridging population to 
introduce the inﬂuenza A virus strains that are being ampliﬁed in the 
CAFOs to their surrounding human communities.”  
“Modern swine production techniques may have contributed to novel 
inﬂuenza virus generation.” 
Benefits for public health 
1. Timely identification of novel influenza viruses 
in pigs or changes in SIVs 
2. Trace immediate ancestors of putative swine 
origin pandemic viruses (should they occur) 
3.  Reliable data about the incidence of zoonotic 
SIV infection through targeted virologic 
surveillance 
 
 
Surveillance... 
• is essential for insights in the epidemiology and 
evolution of SIVs, as an alert for new viruses, to 
improve diagnosis .... 
• is a building stone for influenza research 
• may assist in vaccine strain selection, 
implementation of control measures, and 
contribute to determine public health risk 
